MaaT Pharma Announces New Appointments

to the Board and Executive Team.

Lyon, France, June 21, 2023 6:00 pm CET – MaaT Pharma (EURONEXT: MAAT – the “Company”), a clinical-stage biotechnology company and a leader in the development of Microbiome Ecosystem TherapiesTM (MET) dedicated to improving survival outcomes for patients with cancer, today announced new appointments to its Board and Executive team.

Karim Dabbagh as Chairman and Nadia Kamal as Director, both independent.
Pr. Gervais Tougas, acting Chief Medical Officer and Philippe Moyen, Chief Operating Officer.
Appointment of Guilhaume Debroas as Head of Investor Relations.

All resolutions presented during the annual general meeting were adopted in line with the Board recommendations.

Read the press release